Results and Conclusions EMEA's Drug registration system is more flexible, but there are also some problems in it, such as the centralized procedure is a bit rigid etc.
结果与结论EMEA审评体系较为便利灵活，但也存在中央程序僵化、管理资源重复浪费等问题。
Results and Conclusions EMEA's Drug registration system is more flexible, but there are also some problems in it, such as the centralized procedure is a bit rigid etc.
结果与结论EMEA审评体系较为便利灵活，但也存在中央程序僵化、管理资源重复浪费等问题。
应用推荐